The percentages of MDSCs and CD68+CD163+M2-like macrophages were analyzed by flow cytometry in healthy controls (HC) and NSCLC patients (Figures 1(a) and 1(b), Figure S1). This evidence concerns the gene CD68 and non-small cell lung carcinoma.